Contract Secured with St. Jude Childrens Research Hospital
| Stock | Enlitic Inc (ENL.ASX) |
|---|---|
| Release Time | 31 Mar 2026, 9:28 a.m. |
| Price Sensitive | Yes |
Enlitic Secures Contract with St. Jude Children's Research Hospital
- Contract valued at US$250,000 for data migration services
- Potential to adopt Enlitic's AI-powered data management platform, Ensight
- First commercial engagement in the paediatric healthcare sector
- Expands addressable market and provides strong third-party validation
Enlitic, Inc. (ASX: ENL) has entered into a new collaboration agreement with St. Jude Children's Research Hospital ('St. Jude'), a globally recognised not-for-profit paediatric care institution in Memphis, Tennessee, for the deployment of its core data migration technology. St. Jude is a world-leading academic medical centre focused on advancing cures and improving outcomes for children with cancer and other life-threatening diseases. The institution combines high-volume clinical care with world-leading research programs and large-scale data-driven initiatives, positioning it at the forefront of paediatric oncology and precision medicine. Under the terms of the agreement, Enlitic will provide migration services to St. Jude valued at US$250,000. Significantly, the migration services contract provides the catalyst for St. Jude to potentially access Enlitic's AI-powered data management platform, Ensight, which delivers a cohort of higher-margin SaaS-based offerings on top of the Company's core data migration initiatives. The Ensight platform is an enterprise SaaS imaging solution that enables healthcare providers to efficiently access, manage and utilise large-scale medical imaging datasets, supporting streamlined workflows, improved interoperability and the deployment of advanced analytics and AI-driven applications. The arrangements with St Jude represent Enlitic's first commercial engagement within the paediatric healthcare sector, providing a strategic entry point into a highly specialised and research-intensive segment of the global healthcare market. Establishing a relationship with an institution of St. Jude's calibre provides strong third-party validation of Enlitic's platform and creates potential to expand into adjacent paediatric and research-led health systems, supporting long-term growth in both clinical and research data management applications.
The growing number of migration contracts provides Enlitic with multiple channels to roll out and integrate its AI-driven Ensight offering, which has exceptional functionality and considerable commercial appeal to customers.